| dc.contributor.advisor | Šafář, Petr | |
| dc.creator | Bjorke, Cathrine Amalie | |
| dc.date.accessioned | 2018-09-12T10:17:10Z | |
| dc.date.available | 2018-09-12T10:17:10Z | |
| dc.date.issued | 2008 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.11956/14175 | |
| dc.description.abstract | Cervical cancer is the second most common form of cancer in women in the developing world, but the incidence is generally lower in the Western part of the world. In Europe approximately 52 000 women are diagnosed each year, of which 27 000 die of the disease. Every day a woman gets diagnosed with cervical cancer, while almost ten women receives the diagnosis of severe pre malignant state. The disease is the second most common cause of death due to cancer among women globally and lead to ca. 190 000 deaths annually. In Norway a national mass examination program against cervical cancer has been in practice since 1995. The aim is to reduce prevalence and mortality while at the same time promote rational testing procedures. | en_US |
| dc.language | English | cs_CZ |
| dc.language.iso | en_US | |
| dc.publisher | Univerzita Karlova, 3. lékařská fakulta | cs_CZ |
| dc.title | Prevention of cervical cancer - The National Screening program in Norway | en_US |
| dc.type | diplomová práce | cs_CZ |
| dcterms.created | 2008 | |
| dcterms.dateAccepted | 2008-04-01 | |
| dc.description.department | Ústav pro péči o matku a dítě v Praze Podolí | cs_CZ |
| dc.description.department | Department of Mother and Child Care in Prague Podoli | en_US |
| dc.description.faculty | Third Faculty of Medicine | en_US |
| dc.description.faculty | 3. lékařská fakulta | cs_CZ |
| dc.identifier.repId | 13624 | |
| dc.title.translated | Prevence rakoviny děložního hrdla - Národní screeningový program v Norsku | cs_CZ |
| dc.identifier.aleph | 000974787 | |
| thesis.degree.name | MUDr. | |
| thesis.degree.level | magisterské | cs_CZ |
| thesis.degree.discipline | - | cs_CZ |
| thesis.degree.discipline | - | en_US |
| thesis.degree.program | General Medicine | en_US |
| thesis.degree.program | Všeobecné lékařství | cs_CZ |
| uk.thesis.type | diplomová práce | cs_CZ |
| uk.taxonomy.organization-cs | 3. lékařská fakulta::Ústav pro péči o matku a dítě v Praze Podolí | cs_CZ |
| uk.taxonomy.organization-en | Third Faculty of Medicine::Department of Mother and Child Care in Prague Podoli | en_US |
| uk.faculty-name.cs | 3. lékařská fakulta | cs_CZ |
| uk.faculty-name.en | Third Faculty of Medicine | en_US |
| uk.faculty-abbr.cs | 3.LF | cs_CZ |
| uk.degree-discipline.cs | - | cs_CZ |
| uk.degree-discipline.en | - | en_US |
| uk.degree-program.cs | Všeobecné lékařství | cs_CZ |
| uk.degree-program.en | General Medicine | en_US |
| thesis.grade.cs | Výborně | cs_CZ |
| thesis.grade.en | Excellent | en_US |
| uk.abstract.en | Cervical cancer is the second most common form of cancer in women in the developing world, but the incidence is generally lower in the Western part of the world. In Europe approximately 52 000 women are diagnosed each year, of which 27 000 die of the disease. Every day a woman gets diagnosed with cervical cancer, while almost ten women receives the diagnosis of severe pre malignant state. The disease is the second most common cause of death due to cancer among women globally and lead to ca. 190 000 deaths annually. In Norway a national mass examination program against cervical cancer has been in practice since 1995. The aim is to reduce prevalence and mortality while at the same time promote rational testing procedures. | en_US |
| uk.file-availability | V | |
| uk.publication.place | Praha | cs_CZ |
| uk.grantor | Univerzita Karlova, 3. lékařská fakulta, Ústav pro péči o matku a dítě v Praze Podolí | cs_CZ |
| thesis.grade.code | 1 | |
| dc.identifier.lisID | 990009747870106986 | |
